{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:36:09Z","timestamp":1790872569190,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271400"],"award-info":[{"award-number":["32271400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470146"],"award-info":[{"award-number":["32470146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170144"],"award-info":[{"award-number":["32170144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.actbio.2025.04.023","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T03:27:00Z","timestamp":1744255620000},"page":"115-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Engineered bioorthogonal cell delivery system for in situ antimicrobial peptide recruitment during systemic bacterial infection"],"prefix":"10.1016","volume":"198","author":[{"given":"Wenchang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingye","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-5560","authenticated-orcid":false,"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10219","key":"10.1016\/j.actbio.2025.04.023_bib0001","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortalit, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0002","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discovery"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.023_bib0003","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","article-title":"Mechanisms and treatment of organ failure in sepsis","volume":"14","author":"Lelubre","year":"2018","journal-title":"Nature Reviews Nephrology"},{"issue":"10219","key":"10.1016\/j.actbio.2025.04.023_bib0004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(19)33065-X","article-title":"A global accounting of sepsis","volume":"395","author":"Kempker","year":"2020","journal-title":"The Lancet"},{"issue":"10219","key":"10.1016\/j.actbio.2025.04.023_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nature Immunology"},{"issue":"9","key":"10.1016\/j.actbio.2025.04.023_bib0007","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1473-3099(09)70135-5","article-title":"Surviving sepsis in low-income and middle-income countries: new directions for care and research","volume":"9","author":"Becker","year":"2009","journal-title":"The Lancet. Infectious diseases"},{"issue":"10325","key":"10.1016\/j.actbio.2025.04.023_bib0008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.actbio.2025.04.023_bib0009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries","volume":"6","author":"Sands","year":"2021","journal-title":"Nature Microbiology"},{"issue":"6","key":"10.1016\/j.actbio.2025.04.023_bib0010","doi-asserted-by":"crossref","first-page":"BE11","DOI":"10.1038\/89382","article-title":"Cell Based Delivery","volume":"19","author":"Dorey","year":"2001","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41589-021-00899-z","article-title":"Genetic-code-expanded cell-based therapy for treating diabetes in mice","volume":"18","author":"Chen","year":"2022","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0012","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","article-title":"The Emerging Landscape of Immune Cell Therapies","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting Strategies for Tissue-Specific Drug Delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0014","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s44222-024-00214-0","article-title":"Designing drug delivery systems for cell therapy","volume":"2","author":"Wang","year":"2024","journal-title":"Nature Reviews Bioengineering"},{"issue":"13","key":"10.1016\/j.actbio.2025.04.023_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007379","article-title":"Polymerization-Mediated Multifunctionalization of Living Cells for Enhanced Cell-Based Therapy","volume":"33","author":"Pan","year":"2021","journal-title":"Advanced Materials"},{"issue":"12","key":"10.1016\/j.actbio.2025.04.023_bib0016","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41551-024-01255-x","article-title":"Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies","volume":"8","author":"Kapetanovic","year":"2024","journal-title":"Nature Biomedical Engineering"},{"issue":"4961","key":"10.1016\/j.actbio.2025.04.023_bib0017","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/204850a0","article-title":"Facilitation of Host Lymphoid Tissue Development in Neonatally Thymectomized Mice by Injection of Allogeneic Dispersed Thymus Cells","volume":"204","author":"Yunis","year":"1964","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0018","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1038\/s41467-024-52400-8","article-title":"Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses","volume":"15","author":"Douvaras","year":"2024","journal-title":"Nature Communications"},{"issue":"10","key":"10.1016\/j.actbio.2025.04.023_bib0019","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrd.2017.106","article-title":"Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics","volume":"16","author":"Cahill","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13306","article-title":"Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction","volume":"7","author":"Zhao","year":"2016","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0021","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41467-024-44905-z","article-title":"A phase 1\/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome","volume":"15","author":"Hammond","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0022","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-019-09913-4","article-title":"Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace","volume":"10","author":"Jardine","year":"2019","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.023_bib0023","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nature Reviews Immunology"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.023_bib0024","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nri3087","article-title":"Studying the mononuclear phagocyte system in the molecular age","volume":"11","author":"Chow","year":"2011","journal-title":"Nature Reviews Immunology"},{"issue":"12","key":"10.1016\/j.actbio.2025.04.023_bib0025","doi-asserted-by":"crossref","first-page":"eaam6202","DOI":"10.1126\/sciimmunol.aam6202","article-title":"Donor SIRP\u03b1 polymorphism modulates the innate immune response to allogeneic grafts","volume":"2","author":"Dai","year":"2017","journal-title":"Science Immunology"},{"issue":"43","key":"10.1016\/j.actbio.2025.04.023_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210059","article-title":"Materials for Cell Surface Engineering","volume":"36","author":"Adebowale","year":"2023","journal-title":"Advanced Materials"},{"issue":"9","key":"10.1016\/j.actbio.2025.04.023_bib0027","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/j.actbio.2025.04.023_bib0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2021.11.001","article-title":"Barnase*Barstar-guided two-step targeting approach for drug delivery to tumor cells in vivo","volume":"340","author":"Shramova","year":"2021","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"issue":"10","key":"10.1016\/j.actbio.2025.04.023_bib0029","doi-asserted-by":"crossref","first-page":"eadk9485","DOI":"10.1126\/sciadv.adk9485","article-title":"Upconversion dual-photosensitizer\u2013expressing bacteria for near-infrared monochromatically excitable synergistic phototherapy","volume":"10","author":"Chen","year":"2024","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.actbio.2025.04.023_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207194","article-title":"An Inter-Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci"},{"key":"10.1016\/j.actbio.2025.04.023_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114300","article-title":"Mesenchymal stem cells: A living carrier for active tumor-targeted delivery","volume":"185","author":"Zhang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"30","key":"10.1016\/j.actbio.2025.04.023_bib0032","doi-asserted-by":"crossref","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.023_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071613","article-title":"Application of Stem Cell Therapy for Infertility","volume":"10","author":"Saha","year":"2021","journal-title":"Cells"},{"issue":"7769","key":"10.1016\/j.actbio.2025.04.023_bib0034","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5700853","article-title":"Adapted Murine Sepsis Score: Improving the Research in Experimental Sepsis Mouse Model","volume":"2022","author":"Sulzbacher","year":"2022","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0036","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41467-021-22898-3","article-title":"Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic","volume":"12","author":"Zhang","year":"2021","journal-title":"Nature Communications"},{"issue":"7866","key":"10.1016\/j.actbio.2025.04.023_bib0037","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0038","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.actbio.2025.04.023_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210058","article-title":"Adoptive cell therapy for cancer treatment","volume":"3","author":"Du","year":"2023","journal-title":"Exploration"},{"issue":"9","key":"10.1016\/j.actbio.2025.04.023_bib0040","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1016\/S2352-3026(23)00114-X","article-title":"Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care","volume":"10","author":"Sp\u00e4th","year":"2023","journal-title":"The Lancet Haematology"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0041","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-024-03282-2","article-title":"Allogeneic CD5-specific CAR-T therapy for relapsed\/refractory T-ALL: a phase 1 trial","volume":"31","author":"Pan","year":"2025","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/j.actbio.2025.04.023_bib0042","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri.2016.29","article-title":"The immunology of host defence peptides: beyond antimicrobial activity","volume":"16","author":"Hancock","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1016\/j.actbio.2025.04.023_bib0043","first-page":"32","article-title":"The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent","volume":"10","author":"Ridyard","year":"2021","journal-title":"Antibiotics-Basel"},{"issue":"2","key":"10.1016\/j.actbio.2025.04.023_bib0044","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0045","article-title":"G-CSF Inhibits Pulmonary Fibrosis by Promoting BMSC Homing to the Lungs via SDF-1\/CXCR4 Chemotaxis","volume":"10","author":"Zhao","year":"2020","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.023_bib0046","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","article-title":"Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue","volume":"6","author":"Wang","year":"2022","journal-title":"Nature Biomedical Engineering"},{"issue":"8","key":"10.1016\/j.actbio.2025.04.023_bib0047","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"10.1016\/j.actbio.2025.04.023_bib0048","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","article-title":"The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities","volume":"25","author":"Ponte","year":"2007","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0049","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1038\/s41467-024-50021-9","article-title":"Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery","volume":"15","author":"Li","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.actbio.2025.04.023_bib0050","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.023_bib0051","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41551-024-01230-6","volume":"8","author":"Wang","year":"2024","journal-title":"Nature Biomedical Engineering"},{"issue":"11","key":"10.1016\/j.actbio.2025.04.023_bib0052","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.matt.2021.09.001","article-title":"Targeting multiple mediators of sepsis using multifunctional tannic acid-Zn2+-gentamicin nanoparticles","volume":"4","author":"Liu","year":"2021","journal-title":"Matter"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612500265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612500265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:58:04Z","timestamp":1762556284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270612500265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S174270612500265X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.023","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered bioorthogonal cell delivery system for in situ antimicrobial peptide recruitment during systemic bacterial infection","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}